Literature DB >> 28702876

Cardiovascular Histopathology of a 11-Year Old with Mucopolysaccharidosis VII Demonstrates Fibrosis, Macrophage Infiltration, and Arterial Luminal Stenosis.

Valerie Lew1, Louis Pena2,3, Robert Edwards4, Raymond Y Wang5,6.   

Abstract

Mucopolysaccharidosis type VII (MPS VII) is caused by β-glucuronidase deficiency, resulting in lysosomal accumulation of glycosaminoglycans (GAGs) and multisystemic disease. We present cardiovascular gross and histopathology findings from a 11-year-old MPS VII male, who expired after developing ventricular fibrillation following anesthesia induction. Gross anatomic observations were made at autopsy; postmortem formalin-fixed paraffin-embedded samples of the carotid artery, aorta, myocardium, and valves were sectioned and stained with hematoxylin-eosin, Verhoeff-Van Gieson, CD68, and trichrome stains. Gross heart findings include an enlarged, dilated heart, mitral valve prolapse with thick, shortened chordae tendinae, and thickened aortic valve cusps. The aorta contained raised intimal plaques mimicking conventional atherosclerosis. Cardiac myocytes included hypertrophic nuclei, subendocardial fibrosis, and increased interfascicular collagen. Coronary lumens were 40-70% stenosed by fibrointimal hyperplasia containing storage material-laden cells, CD68+ macrophages, and fragmented elastin laminae. Similar findings were visualized in aortic intimal plaques. We confirm that arterial plaques, elastin fragmentation, and activated CD68+ macrophage infiltration occur in human MPS VII, consistent with previously observed findings in murine and canine MPS VII. We also confirm ultrasonographically observed carotid intimal-medial thickening is an in vivo correlate of histopathologic vascular fibrointimal hyperplasia. MPS VII patients should be regularly monitored for cardiac disease, with methods such as Holter monitors and stress testing; MPS VII-directed treatments should effectively address cardiovascular disease.

Entities:  

Keywords:  Cardiovascular; Histopathology; Mucopolysaccharidosis VII; Outcome; Postmortem; Sly syndrome

Year:  2017        PMID: 28702876      PMCID: PMC5953895          DOI: 10.1007/8904_2017_43

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  17 in total

1.  Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII.

Authors:  C Sammarco; M Weil; C Just; S Weimelt; C Hasson; T O'Malley; S M Evans; P Wang; M L Casal; J Wolfe; M Haskins
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

Review 2.  Overview of the mucopolysaccharidoses.

Authors:  Joseph Muenzer
Journal:  Rheumatology (Oxford)       Date:  2011-12       Impact factor: 7.580

3.  Cardiovascular pathologies in mucopolysaccharidosis type VII (Sly Syndrome).

Authors:  Thomas J Gniadek; Nicole Singer; Norman J Barker; Philip J Spevak; Barbara J Crain; David Valle; Marc K Halushka
Journal:  Cardiovasc Pathol       Date:  2015-06-19       Impact factor: 2.185

4.  Mucopolysaccharidosis type VII associated with hydrops fetalis: histopathological and ultrastructural features with genetic implications.

Authors:  A J Molyneux; E Blair; N Coleman; P Daish
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

5.  Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.

Authors:  Paul W Bigg; Guilherme Baldo; Meg M Sleeper; Patricia A O'Donnell; Hanqing Bai; Venkata R P Rokkam; Yuli Liu; Susan Wu; Roberto Giugliani; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-06-25       Impact factor: 4.797

6.  Subendocardial ischemic myocardial lesions associated with severe coronary atherosclerosis.

Authors:  J C Geer; C A Crago; W C Little; L L Gardner; S P Bishop
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

7.  Mucopolysaccharidosis VII (Sly disease) as a cause of increased nuchal translucency and non-immune fetal hydrops: study of a family and technical approach to prenatal diagnosis in early and late pregnancy.

Authors:  A Geipel; C Berg; U Germer; M Krapp; M Kohl; U Gembruch
Journal:  Prenat Diagn       Date:  2002-06       Impact factor: 3.050

8.  Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.

Authors:  Jason A Metcalf; Bruce Linders; Susan Wu; Paul Bigg; Patricia O'Donnell; Meg M Sleeper; Michael P Whyte; Mark Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

9.  Clinical course of sly syndrome (mucopolysaccharidosis type VII).

Authors:  Adriana M Montaño; Ngu Lock-Hock; Robert D Steiner; Brett H Graham; Marina Szlago; Robert Greenstein; Mercedes Pineda; Antonio Gonzalez-Meneses; Mahmut Çoker; Dennis Bartholomew; Mark S Sands; Raymond Wang; Roberto Giugliani; Alfons Macaya; Gregory Pastores; Anastasia K Ketko; Fatih Ezgü; Akemi Tanaka; Laila Arash; Michael Beck; Rena E Falk; Kaustuv Bhattacharya; José Franco; Klane K White; Grant A Mitchell; Loreta Cimbalistiene; Max Holtz; William S Sly
Journal:  J Med Genet       Date:  2016-02-23       Impact factor: 6.318

10.  Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I.

Authors:  Omar Khalid; Moin U Vera; Philip L Gordts; N Matthew Ellinwood; Philip H Schwartz; Patricia I Dickson; Jeffrey D Esko; Raymond Y Wang
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

View more
  5 in total

1.  Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy.

Authors:  Fabiano de Oliveira Poswar; Carolina Fischinger Moura de Souza; Roberto Giugliani; Guilherme Baldo
Journal:  Heart Vessels       Date:  2018-08-22       Impact factor: 2.037

2.  Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease.

Authors:  Brittany Montavon; Linda E Winter; Qi Gan; Amirhossein Arasteh; Adriana M Montaño
Journal:  Front Cardiovasc Med       Date:  2022-05-10

Review 3.  Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.

Authors:  Hira Peracha; Kazuki Sawamoto; Lauren Averill; Heidi Kecskemethy; Mary Theroux; Mihir Thacker; Kyoko Nagao; Christian Pizarro; William Mackenzie; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji Orii; Tadao Orii; Toshiyuki Fukao; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-05-15       Impact factor: 4.797

4.  Non-progressive Nonimmune Hydrops Fetalis Caused by a Novel Mutation in GUSB Gene.

Authors:  Asieh Mosallanejad; Mohammadreza Alaei; Saeed Reza Ghaffari; Maryam Rafati; Hedyeh Saneifard
Journal:  Iran J Child Neurol       Date:  2020

5.  Abnormally increased carotid intima media-thickness and elasticity in patients with Morquio A disease.

Authors:  Raymond Y Wang; Kyle D Rudser; Donald R Dengel; Nicholas Evanoff; Julia Steinberger; Nina Movsesyan; Robert Garrett; Katherine Christensen; Deborah Boylan; Stephen R Braddock; Marwan Shinawi; Qi Gan; Adriana M Montaño
Journal:  Orphanet J Rare Dis       Date:  2020-03-17       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.